vTv Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview

vTv Therapeutics

08/05/2023 11:08

* vTv Therapeutics Inc  VTVT.OQ   VTVT.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 10
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for vTv Therapeutics
Inc is
for a loss of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $3​, above​ its last closing price of $0.75. ​​​

This summary was machine generated May 8 at 10:08 GMT.  All
figures in US dollars  unless otherwise stated